SecBot SecBot
8-K ·Filed Aug 6, 2026

TNGX

Tango Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001193125-26-338480
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine executive departure with no financial guidance or operational changes. Monitor for any future 8-K regarding a replacement for the Executive Chair role, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$27.07
T+0 close · Aug 6, 2026 · via day close
Latest settled
−16.99%
T+60 · $22.47
Vs SPY
−14.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 7 $27.07entry
  2. T+1 · 3mo ago +2.22%α +2.25% · $27.67
  3. T+5 · 3mo ago −5.43%α −5.83% · $25.60
  4. T+20 · 2mo ago −16.81%α −16.41% · $22.52
  5. T+60 · 15d ago −16.99%α −14.86% · $22.47
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Tango Therapeutics disclosed the end of Dr. Barbara Weber's employment as Executive Chair, effective August 3, 2026, with her resignation from all officer and board positions. The departure is not due to any disagreement with the company, and a separation agreement with standard severance benefits has been offered. This is a routine executive transition with no financial impact disclosed, making it a neutral event for the stock.

Key Facts

  • Dr. Barbara Weber's employment as Executive Chair ended on August 3, 2026.
  • Dr. Weber resigned from all officer and board member positions, including the board of directors.
  • The resignation was not a result of any disagreement with the company.
  • The company offered severance pay through December 31, 2026, COBRA reimbursement, and accelerated vesting of certain equity awards.
  • CEO Malte Peters remains in place; no other executive changes were announced.

Financial Impact

Severance pay at current base salary through Dec 31, 2026, plus COBRA reimbursement and accelerated vesting of 12 months of equity awards, amounts not disclosed.

Risk Factors

  • Potential leadership vacuum if a new Executive Chair is not named promptly.
  • Minor overhang from accelerated equity vesting, though amounts are undisclosed.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-338480
Document: 0001193125-26-338480-index-headers.html0001193125-26-338480
Document: 0001193125-26-338480-index.html0001193125-26-338480
Document: 0001193125-26-338480.txt0001193125-26-338480

Track record

27 reports on TNGX

Performance horizon

3 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +29.28% at T+60 after the Jun 8, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.22 Now $24.17 +0.21% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.50 Now $24.17 +1.35% settles Feb 12
  3. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $22.74 Now $24.17 +6.29% settles Feb 5
  4. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $21.50 Now $24.17 +12.42% settles Feb 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $20.87 Now $24.17 +15.81% settles Feb 3
  6. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
  8. Oct 23, 202624d ago 8-K Bullish 7/10 Entry $23.34 Now $24.17 +3.56% settles Jan 21
  9. Aug 11, 202613w ago 8-K Bearish 6/10 Entry $25.58 to $23.18 Now $24.17 +5.51% ▲ +9.38% +4.51% vs SPY
  10. Aug 11, 202613w ago 8-K Bullish 7/10 No price data
Showing 10 of 27

US Market Status

Market Closed · Opens in 9h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 6, 2026